Latham & Watkins represented the placement agents in the offering.UroGen Pharma Ltd. (Nasdaq: URGN) announced that it has entered into a definitive securities purchase agreement in…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Pietro Martinoia
…
This content is for Standard 1 Year members only. LoginJoin Now